Algert Global’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-65,510
| Closed | -$108K | – | 1227 |
|
|
2024
Q4 | $108K | Sell |
65,510
-101
| -0.2% | -$167 | ﹤0.01% | 1114 |
|
|
2024
Q3 | $230K | Hold |
65,611
| – | – | 0.01% | 1049 |
|
|
2024
Q2 | $215K | Buy |
65,611
+49,931
| +318% | +$164K | 0.01% | 1252 |
|
|
2024
Q1 | $115K | Sell |
15,680
-64,974
| -81% | -$477K | ﹤0.01% | 1006 |
|
|
2023
Q4 | $302K | Sell |
80,654
-11,210
| -12% | -$42K | 0.01% | 938 |
|
|
2023
Q3 | $195K | Sell |
91,864
-444,967
| -83% | -$945K | 0.01% | 971 |
|
|
2023
Q2 | $2.56M | Buy |
536,831
+156,294
| +41% | +$744K | 0.11% | 310 |
|
|
2023
Q1 | $2.17M | Buy |
+380,537
| New | +$2.17M | 0.1% | 316 |
|
|
2022
Q2 | – | Sell |
-21,356
| Closed | -$828K | – | 1261 |
|
|
2022
Q1 | $828K | Buy |
21,356
+12,245
| +134% | +$475K | 0.05% | 600 |
|
|
2021
Q4 | $533K | Buy |
9,111
+1,190
| +15% | +$69.6K | 0.07% | 514 |
|
|
2021
Q3 | $469K | Buy |
+7,921
| New | +$469K | 0.06% | 559 |
|
|
2018
Q2 | – | Sell |
-17,580
| Closed | -$172K | – | 345 |
|
|
2018
Q1 | $172K | Buy |
+17,580
| New | +$172K | 0.03% | 312 |
|
|
2017
Q4 | – | Sell |
-70,677
| Closed | -$280K | – | 317 |
|
|
2017
Q3 | $280K | Sell |
70,677
-31,492
| -31% | -$125K | 0.06% | 264 |
|
|
2017
Q2 | $331K | Buy |
+102,169
| New | +$331K | 0.09% | 241 |
|